Literature DB >> 24412498

Synthesis and assay of retro-α4β1 integrin-targeting motifs.

Samantha D Dattoli1, Rossella De Marco2, Monica Baiula1, Santi Spampinato3, Arianna Greco4, Alessandra Tolomelli4, Luca Gentilucci5.   

Abstract

In recent years, several research groups proposed new peptidomimetic antagonists of integrins αvβ3, α5β1, αIIbβ3, αvβ6, αvβ5, etc. based on retro sequences of the classic integrin-binding motif RGD. The retro strategy is still largely ignored for the non-RGD-binding α4β1 integrin. Herein we present the first examples of retro sequences for targeting this integrin, composed of Asp or isoAsp equipped with an aromatic cap at the N-terminus, (S)-pyrrolidine-3-carboxylic acid (β(2)-Pro) as a constrained core, and the amino variant (AMPUMP) of the well-known α4-targeting diphenylurea MPUPA. We discuss α4β1 receptor affinity (SPA), cell adhesion assays, stability in mouse serum, and conformational analysis. For their significant ability to inhibit cell adhesion and remarkable stability, the retro-peptide mimetics BnCO-Asp-β-Pro-AMPUMP (3) and BnCO-isoAsp-β-Pro-AMPUMP (4) represent promising candidates for designing small molecules as potential anti-inflammatory agents.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cell adhesion inhibition; Diphenylurea; Isoaspartate; Peptidomimetics; Retro sequences; Scintillation proximity assay; VLA-4 ligands; β(2)-Proline

Mesh:

Substances:

Year:  2013        PMID: 24412498     DOI: 10.1016/j.ejmech.2013.12.009

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Dehydro-β-proline Containing α4β1 Integrin Antagonists: Stereochemical Recognition in Ligand-Receptor Interplay.

Authors:  Alessandra Tolomelli; Monica Baiula; Angelo Viola; Lucia Ferrazzano; Luca Gentilucci; Samantha Deianira Dattoli; Santi Spampinato; Eusebio Juaristi; Margarita Escudero
Journal:  ACS Med Chem Lett       Date:  2015-05-05       Impact factor: 4.345

2.  DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs.

Authors:  Samantha Deianira Dattoli; Monica Baiula; Rossella De Marco; Andrea Bedini; Michele Anselmi; Luca Gentilucci; Santi Spampinato
Journal:  Br J Pharmacol       Date:  2018-09-17       Impact factor: 8.739

Review 3.  The role of integrins in melanoma: a review.

Authors:  Suzette M Arias-Mejias; Katerina Y Warda; Enrica Quattrocchi; Hector Alonso-Quinones; Sindhuja Sominidi-Damodaran; Alexander Meves
Journal:  Int J Dermatol       Date:  2020-03-10       Impact factor: 2.736

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.